Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexander Scheffold is active.

Publication


Featured researches published by Alexander Scheffold.


Journal of Immunology | 2010

Cutting Edge: Plasmacytoid Dendritic Cells Induce IL-10 Production in T Cells via the Delta-Like-4/Notch Axis

Nadine Kassner; Manuela Krueger; Hideo Yagita; Andrzej Dzionek; Andreas Hutloff; Richard A. Kroczek; Alexander Scheffold; Sascha Rutz

Proinflammatory Th1 cells can produce large amounts of the immunosuppressive cytokine IL-10, thereby facilitating the self-limitation of inflammatory responses. Recently, we identified the Notch pathway as a main regulator of IL-10 production by Th1 cells. In this study, we show that plasmacytoid dendritic cells (pDCs), by means of their unique high-level expression of the Notch ligand Delta-like (Dll)-4, activate the Notch receptor on T cells to induce robust IL-10 production in vitro and in vivo. pDCs display a distinct pattern of Notch ligands compared with conventional dendritic cells, marked by the constitutive expression of Dll-4, the only Notch ligand to induce IL-10 expression in vivo, and Dll-1, while at the same time lacking the expression of Jagged. We provide a new mechanism for IL-10 induction by pDCs underlining the importance of the Dll-4/Notch axis in the regulation of inflammatory T cell responses.


Arthritis & Rheumatism | 2011

Origin and Functional Activity of the Membrane-Bound Glucocorticoid Receptor

Cindy Strehl; Timo Gaber; Mark Löwenberg; Daniel W. Hommes; Auke Verhaar; Saskia Schellmann; M. Hahne; Monique Fangradt; Markus Wagegg; Paula Hoff; Alexander Scheffold; Cornelia M. Spies; Gerd-Rüdiger Burmester; Frank Buttgereit

OBJECTIVEnGlucocorticoids (GCs) exert their antiinflammatory and immunosuppressive effects in humans primarily via the cytosolic GC receptor (cGR) but also via rapid, nongenomic mechanisms. Most likely, membrane-bound GRs (mGR) are involved in nongenomic GC signaling. The aim of this study was to investigate the origin and functional activity of mGR.nnnMETHODSnWe analyzed the origin of mGR using mGR-expressing HEK 293T cells, by transient and stable RNA interference-mediated GR reduction. GR messenger RNA (mRNA) and cGR and mGR protein levels were analyzed by real-time quantitative polymerase chain reaction, immunoblotting, and high-sensitivity immunofluorescence staining. Furthermore, we analyzed the functional activity of mGR, using membrane-impermeable bovine serum albumin (BSA)-bound dexamethasone (DEX-BSA) in human monocytes. Membrane-bound GR-expressing monocytes were treated with DEX, DEX-BSA, or BSA. Cell lysates were analyzed using PepChip arrays in order to identify kinases triggered by DEX-BSA, with validation using Bio-Plex assays and immunoblotting.nnnRESULTSnOur data showed that transient reduction of GR mRNA in HEK 293T cells decreased cGR protein levels but not mGR protein levels. However, stably transfected cells showed reduced cGR protein expression and significantly reduced mGR protein expression. Furthermore, 51 kinase substrates were identified for which phosphorylation was either reduced or increased. We observed p38 MAP kinase (MAPK) as one possible upstream kinase. Validation of these data by Bio-Plex phosphoprotein assay and immunoblotting showed increased phosphorylation of p38 MAPK after treatment with DEX-BSA.nnnCONCLUSIONnOur data demonstrate that the human GR gene encodes for both cGR and mGR. Membrane-bound GR retains functional activity, as indicated by induced phosphorylation of p38 MAPK due to DEX-BSA treatment. Membrane-bound GR-mediated cellular signaling needs to be investigated further in order to clarify its therapeutic potential.


European Journal of Immunology | 2010

In vitro-induced Th17 cells fail to induce inflammation in vivo and show an impaired migration into inflamed sites

Marko Janke; Michael Peine; Alexia Nass; Lars Morawietz; Alf Hamann; Alexander Scheffold

Recently, IL‐17 produced by Th17 cells was described as pro‐inflammatory cytokine with an eminent role in autoimmune diseases, e.g. rheumatoid arthritis. A lack of IL‐17 leads to amelioration of collagen‐induced arthritis. IL‐17 induction in naïve CD4+ T cells depends on IL‐6 and TGF‐β and is enhanced by IL‐23. The in vivo inflammatory potential of in vitro‐primed Th17 cells however, remains unclear. Here, we show that, although IL‐17 neutralisation results in amelioration of murine OVA‐induced arthritis, in vitro‐primed Th17 cells cannot exacerbate arthritic symptoms after adoptive transfer. Furthermore, Th17 cells cannot induce an inflammatory delayed type hypersensitivity reaction because they fail to migrate into inflamed sites, possibly due to the lack of CXCR3 expression. Also, re‐isolated Th17 cells acquired IFN‐γ expression, indicating instability of the Th17 phenotype. Taken together, the data show that IL‐6, TGF‐β and IL‐23 might not provide sufficient signals to induce “fully qualified” Th17 cells.


Biospektrum | 2012

Anreicherung und durchflusszytometrischer Nachweis sehr seltener Zelltypen

Dorothee Köhler; Petra Bacher; Alexander Scheffold; Mario Assenmacher; Manuela Herber

We describe the magnetic enrichment and flow cytometric analysis of defined cell types in a single automated workflow using a new flow cytometry system. This procedure facilitates the fast and reproducible enrichment, quantification, and characterization of rare cells. The approach holds great promise for the routine analysis of, for example, circulating tumor cells or antigen-specific T cells and may provide the technical basis for the development of standardized diagnostic assays.


Archive | 2012

Method and device for cell modification

Stefan Miltenyi; Alexander Scheffold


Archive | 2013

Method for polyclonal stimulation of t cells by mobile nanomatrices

Alexander Scheffold; Mario Assenmacher


Archive | 2012

METHOD FOR THE QUANTITATIVE AND QUALITATIVE CHARACTERIZATION OF ANTIGEN-SPECIFIC T CELLS RECOGNIZING A SPECIFIC ANTIGEN

Alexander Scheffold; Petra Bacher


Archive | 2013

METHOD FOR INDUCING PROLIFERATION OF NATURAL KILLER CELLS BY MOBILE NANOMATRICES

Sabine Müller; Alexander Scheffold; Katharina Oerding; Volker Huppert


Archive | 2010

Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22

Alexander Scheffold; Sascha Rutz; Frederick Xheinrich


Archive | 2016

Immunogenic antigens from Aspergillus fumigatus

Alexander Scheffold; Petra Bacher; Olaf Kniemeyer; Janka Teutschbein; Axel Brakhage

Collaboration


Dive into the Alexander Scheffold's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge